论文部分内容阅读
本文针对目前苦杏仁处方应付不统一的情况,以煎液中的苦杏仁甙含量为指标,对临床上所用苦杏仁的不同样品进行了比较分析,认为苦杏仁的处方应付以统一为蒸品较好。
This article aims at the current situation that the prescription of bitter apricot kernel is not uniform and uses the content of amygdalin in the decoction as an index to compare and analyze the different samples of clinically used bitter apricot kernels. It is considered that the prescription of bitter almonds should be treated as a unified steamed product. it is good.